BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1411639)

  • 1. Clinical trials of teniposide (VM-26) in childhood acute lymphocytic leukemia.
    Rivera GK; Evans WE
    Semin Oncol; 1992 Apr; 19(2 Suppl 6):51-8. PubMed ID: 1411639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teniposide (VM-26) and continuous infusion cytosine arabinoside for initial induction failure in childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Ochs J; Rivera GK; Pollock BH; Buchanan G; Crist W; Freeman AI
    Cancer; 1990 Oct; 66(8):1671-7. PubMed ID: 2208021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teniposide plus cytarabine improves outcome in childhood acute lymphoblastic leukemia presenting with a leukocyte count greater than or equal to 100 x 10(9)/L.
    Dahl GV; Rivera GK; Look AT; Hustu HO; Kalwinsky DK; Abromowitch M; Mirro J; Ochs J; Murphy SB; Dodge RK
    J Clin Oncol; 1987 Jul; 5(7):1015-21. PubMed ID: 3474355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective reinduction therapy for childhood acute nonlymphoid leukemia using simultaneous continuous infusions of teniposide and amsacrine.
    Mirro J; Kalwinsky DK; Grier HE; Santana VM; Mason C; Murphy SB; Dahl GV
    Cancer Chemother Pharmacol; 1989; 24(2):123-7. PubMed ID: 2731312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somnolence, hypotension, and metabolic acidosis following high-dose teniposide treatment in children with leukemia.
    McLeod HL; Baker DK; Pui CH; Rodman JH
    Cancer Chemother Pharmacol; 1991; 29(2):150-4. PubMed ID: 1760858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of refractory and relapsed acute lymphocytic leukemia in adults].
    Bao L; Jiang B; Huang XJ; Wang DB; Qiu JY; Lu XJ; Lu J; Shi HX; Wang FR; Lu DP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):355-7. PubMed ID: 16086050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytosine arabinoside and VM-26 in induction treatment, failures and recurrences of childhood acute lymphoblastic leukemias].
    Navajas Gutiérrez A; Bezanilla Regato JL; Moya Calderón E; Piñán MA
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():91-3. PubMed ID: 3214046
    [No Abstract]   [Full Text] [Related]  

  • 8. A phase II study of combined methotrexate and teniposide infusions prior to reinduction therapy in relapsed childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Ochs J; Rodman J; Abromowitch M; Kavanagh R; Harris M; Yalowich J; Rivera GK
    J Clin Oncol; 1991 Jan; 9(1):139-44. PubMed ID: 1985163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teniposide in the treatment of leukemia: a case study of conflicting priorities in the development of drugs for fatal diseases.
    Grem JL; Hoth DF; Leyland-Jones B; King SA; Ungerleider RS; Wittes RE
    J Clin Oncol; 1988 Feb; 6(2):351-79. PubMed ID: 3276827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia.
    Evans WE; Relling MV; Rodman JH; Crom WR; Boyett JM; Pui CH
    N Engl J Med; 1998 Feb; 338(8):499-505. PubMed ID: 9468466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teniposide in lymphomas and leukemias.
    Sonneveld P
    Semin Oncol; 1992 Apr; 19(2 Suppl 6):59-64. PubMed ID: 1411640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epipodophyllotoxins in the treatment of childhood cancer.
    Rivera GK; Pui CH; Santana VM; Pratt CB; Crist WM
    Cancer Chemother Pharmacol; 1994; 34 Suppl():S89-95. PubMed ID: 8070034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epipodophyllotoxin teniposide in therapy for childhood acute lymphocytic leukemia.
    Rivera GK
    J Clin Oncol; 1988 Feb; 6(2):191-3. PubMed ID: 3276820
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy for initial induction failures in childhood acute lymphoblastic leukemia: a Children's Oncology Group Study (POG 8764).
    Joyce MJ; Pollock BH; Devidas M; Buchanan GR; Camitta B
    J Pediatr Hematol Oncol; 2013 Jan; 35(1):32-5. PubMed ID: 23211688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemia.
    Rivera G; Aur RJ; Dahl GV; Pratt CB; Wood A; Avery TL
    Cancer; 1980 Mar; 45(6):1284-8. PubMed ID: 7357520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etoposide and teniposide in the treatment of acute leukemia.
    Björkholm M
    Med Oncol Tumor Pharmacother; 1990; 7(1):3-10. PubMed ID: 2187120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teniposide plus cytarabine as intensification therapy and in continuation therapy for advanced nonlymphoblastic lymphomas of childhood.
    Maluf PT; Odone Filho V; Cristofani LM; Britto JL; Almeida MT; Pontes E; Maksoud JG; Manissadjian A
    J Clin Oncol; 1994 Sep; 12(9):1963-8. PubMed ID: 8083717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teniposide and cytarabine combination chemotherapy in the treatment of relapsed adolescent and adult acute lymphoblastic leukemia.
    Sanz GF; Sanz MA; Rafecas FJ; Martínez JA; Martín-Aragonés G; Marty ML
    Cancer Treat Rep; 1986 Nov; 70(11):1321-3. PubMed ID: 3464352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemia.
    Rivera G; Dahl GV; Bowman WP; Avery TL; Wood A; Aur RJ
    Cancer; 1980 Oct; 46(8):1727-30. PubMed ID: 6932995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of continuous infusion of methotrexate and teniposide in pediatric cancer patients.
    Rodman JH; Sunderland M; Kavanagh RL; Ochs J; Yalowich J; Evans WE; Rivera GK
    Cancer Res; 1990 Jul; 50(14):4267-71. PubMed ID: 2194652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.